RedHill Biopharma Initiates Phase I/II Study of ABC294640 for Refractory Lymphoma
June 29, 2015 at 07:00 AM EDT
RedHill Biopharma Ltd. (NASDAQ: RDHL) (TASE:RDHL) ("RedHill" or the "Company"), an Israeli biopharmaceutical company focused on late ...